Growth Metrics

GE HealthCare Technologies (GEHC) Cash & Current Investments (2022 - 2026)

GE HealthCare Technologies filings provide 5 years of Cash & Current Investments readings, the most recent being $2.3 billion for Q1 2026.

  • On a quarterly basis, Cash & Current Investments fell 7.71% to $2.3 billion in Q1 2026 year-over-year; TTM through Mar 2026 was $2.3 billion, a 7.71% decrease, with the full-year FY2025 number at $4.5 billion, up 56.07% from a year prior.
  • Cash & Current Investments hit $2.3 billion in Q1 2026 for GE HealthCare Technologies, down from $4.5 billion in the prior quarter.
  • In the past five years, Cash & Current Investments ranged from a high of $4.5 billion in Q4 2025 to a low of $504.0 million in Q3 2022.
  • Median Cash & Current Investments over the past 5 years was $2.4 billion (2023), compared with a mean of $2.4 billion.
  • Biggest five-year swings in Cash & Current Investments: soared 380.16% in 2023 and later dropped 7.71% in 2026.
  • GE HealthCare Technologies' Cash & Current Investments stood at $1.5 billion in 2022, then skyrocketed by 72.71% to $2.5 billion in 2023, then rose by 15.44% to $2.9 billion in 2024, then skyrocketed by 56.07% to $4.5 billion in 2025, then tumbled by 49.39% to $2.3 billion in 2026.
  • The last three reported values for Cash & Current Investments were $2.3 billion (Q1 2026), $4.5 billion (Q4 2025), and $4.0 billion (Q3 2025) per Business Quant data.